• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Edwards Lifesciences (NY: EW )

    67.54 +0.53 (+0.79%)
    Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Edwards Lifesciences

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    $100 Invested In This Stock 20 Years Ago Would Be Worth $3,200 Today
    Via Benzinga
    FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom
    FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document. 
    Via Benzinga
    Exposures Product Safety
    Can financial, healthcare, energy stocks rise as rates stay high?
    Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024. 
    Via MarketBeat
    These Analysts Boost Their Forecasts On Edwards Lifesciences Following Q4 Results
    Edwards Lifesciences Corporation (NYSE: EW) reported in-line earnings for its fourth quarter on Tuesday. 
    Via Benzinga
    Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat
    The company narrowly topped sales expectations and adjusted profit came in line. 
    Via Investor's Business Daily
    Earnings Scheduled For February 6, 2024
    Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
    Via Benzinga
    Edwards Lifesciences Earnings Preview
    Via Benzinga
    Expert Ratings For Edwards Lifesciences
    Via Benzinga
    $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
    Via Benzinga
    Edwards Lifesciences Reports Fourth Quarter Results
    From Edwards Lifesciences Corporation
    Via Business Wire
    Tech Slides, Chinese Stocks Rebound, New York Community Bancorp Tumbles: What's Driving Markets Tuesday?
    At noon trading in New York, major equity indices on Wall Street remain directionless as traders evaluate the future course of monetary policy ahead of several speeches by Federal Reserve officials in... 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    US Stocks Brace For Another Day In The Red As Rally Loses Steam: Analyst Sees Market Pullback On This Indicator
    The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have stalled, with Fed officials remaining non-committal about rate-cut plans. 
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Assessing Edwards Lifesciences: Insights From 14 Financial Analysts
    Via Benzinga
    $100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today
    Via Benzinga
    Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
    From Edwards Lifesciences Corporation
    Via Business Wire
    Biotech And Medtech Portfolio Notes On A Fed Day
    The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    What Happened With Edwards Lifesciences Stock?
    Edwards Lifesciences Corporation (NYSE: EW) shares traded higher on Wednesday. The stock surged despite any company-specific news. 
    Via Benzinga
    Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
    From Edwards Lifesciences Corporation
    Via Business Wire
    Peering Into Edwards Lifesciences's Recent Short Interest
    Via Benzinga
    Deep Dive Into Edwards Lifesciences Stock: Analyst Perspectives (14 Ratings)
    Via Benzinga
    $1000 Invested In This Stock 20 Years Ago Would Be Worth $31,000 Today
    Via Benzinga
    Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Edwards Lifesciences Corporation
    Via Business Wire
    How Is The Market Feeling About Edwards Lifesciences?
    Via Benzinga
    Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
    From Edwards Lifesciences Corporation
    Via Business Wire
    Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 2
    What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Nov. 27 through Dec. 1. 
    Via Talk Markets
    Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years
    Via Benzinga
    Peering Into Edwards Lifesciences's Recent Short Interest
    Via Benzinga
    Analyst Expectations for Edwards Lifesciences's Future
    Via Benzinga
    Zscaler Posts Q1 Results, Joins argenx, Cool Company And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    U.S. stock futures traded mixed this morning, with the Dow Jones futures gaining around 15 points on Tuesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Could Ozempic Harm These 3 Medical Device Stocks?
    The drug is on track to cause massive competitive shifts in the healthcare sector. 
    Via The Motley Fool
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    14 15 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.